Bevasiranib
- Generic Name
- Bevasiranib
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 959961-96-7
- Unique Ingredient Identifier
- DGN36694W4
- Background
Bevasiranib is a small interfering RNA (siRNA) targeting vascular endothelial growth factor A (VEGF-A).
- Indication
Investigated for use/treatment in macular degeneration and diabetic retinopathy.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath